Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Jounce Therapeutics appoints Jigar Raythatha to board of directors » 08:09
09/15/21
09/15
08:09
09/15/21
08:09
JNCE

Jounce Therapeutics

$7.26 /

+0.785 (+12.12%)

Jounce Therapeutics…

Jounce Therapeutics announced the appointment of former CEO of Constellation Pharmaceuticals and former Jounce chief business officer, Jigar Raythatha, to its board of directors.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$7.26 /

+0.785 (+12.12%)

JNCE Jounce Therapeutics
$7.26 /

+0.785 (+12.12%)

09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform with $10 target at Raymond James
09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform from Market Perform at Raymond James
08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
JNCE Jounce Therapeutics
$7.26 /

+0.785 (+12.12%)

  • 10
    Mar
Conference/Events
Robert W. Baird & Co. to hold a virtual conference » 04:55
09/15/21
09/15
04:55
09/15/21
04:55
ABUS

Arbutus Biopharma

$4.25 /

-0.005 (-0.12%)

, AHCO

AdaptHealth

$23.85 /

-0.04 (-0.17%)

, ASMB

Assembly Biosciences

$3.26 /

-0.055 (-1.66%)

, FATE

Fate Therapeutics

$64.86 /

-0.95 (-1.44%)

, STE

Steris

$215.95 /

+5.59 (+2.66%)

, IQV

Iqvia

$257.63 /

+2.01 (+0.79%)

, IVC

Invacare

$5.91 /

-0.62 (-9.49%)

, ICPT

Intercept

$15.15 /

+0.365 (+2.47%)

, HGEN

Humanigen

$6.09 /

-0.155 (-2.48%)

, GERN

Geron

$1.33 /

-0.06 (-4.33%)

, NTRA

Natera

$120.16 /

-0.07 (-0.06%)

, JNCE

Jounce Therapeutics

$7.26 /

+0.785 (+12.12%)

, COO

Cooper Companies

$441.45 /

+0.87 (+0.20%)

, NOVT

Novanta

$150.22 /

-2.125 (-1.39%)

, MYOV

Myovant Sciences

$21.50 /

-1.28 (-5.62%)

, SRPT

Sarepta

$80.18 /

-1.68 (-2.05%)

, RCM

R1 RCM

$20.24 /

-0.17 (-0.83%)

, XRAY

Dentsply Sirona

$61.79 /

-0.05 (-0.08%)

, VIR

Vir Biotechnology

$50.17 /

+0.17 (+0.34%)

, TNDM

TNDM

/

+

, TLMD

SOC Telemed

$2.84 /

-0.07 (-2.41%)

, TRHC

Tabula Rasa HealthCare

$28.82 /

-0.92 (-3.09%)

, ZBH

Zimmer Biomet

$147.63 /

+6.69 (+4.75%)

, MRVL

Marvell

$62.30 /

-0.09 (-0.14%)

, TIL

Instil Bio

$16.45 /

-1.28 (-7.22%)

, TECH

Bio-Techne

$510.50 /

+8.11 (+1.61%)

, TALK

Talkspace

$4.71 /

-0.145 (-2.99%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on September 14-15.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$147.63 /

+6.69 (+4.75%)

XRAY Dentsply Sirona
$61.79 /

-0.05 (-0.08%)

VIR Vir Biotechnology
$50.17 /

+0.17 (+0.34%)

TRHC Tabula Rasa HealthCare
$28.82 /

-0.92 (-3.09%)

TNDM TNDM
/

+

TLMD SOC Telemed
$2.84 /

-0.07 (-2.41%)

TIL Instil Bio
$16.45 /

-1.28 (-7.22%)

TECH Bio-Techne
$510.50 /

+8.11 (+1.61%)

TALK Talkspace
$4.71 /

-0.145 (-2.99%)

STE Steris
$215.95 /

+5.59 (+2.66%)

SRPT Sarepta
$80.18 /

-1.68 (-2.05%)

RCM R1 RCM
$20.24 /

-0.17 (-0.83%)

NTRA Natera
$120.16 /

-0.07 (-0.06%)

NOVT Novanta
$150.22 /

-2.125 (-1.39%)

MYOV Myovant Sciences
$21.50 /

-1.28 (-5.62%)

MRVL Marvell
$62.30 /

-0.09 (-0.14%)

JNCE Jounce Therapeutics
$7.26 /

+0.785 (+12.12%)

IVC Invacare
$5.91 /

-0.62 (-9.49%)

IQV Iqvia
$257.63 /

+2.01 (+0.79%)

ICPT Intercept
$15.15 /

+0.365 (+2.47%)

HGEN Humanigen
$6.09 /

-0.155 (-2.48%)

GERN Geron
$1.33 /

-0.06 (-4.33%)

FATE Fate Therapeutics
$64.86 /

-0.95 (-1.44%)

COO Cooper Companies
$441.45 /

+0.87 (+0.20%)

ASMB Assembly Biosciences
$3.26 /

-0.055 (-1.66%)

AHCO AdaptHealth
$23.85 /

-0.04 (-0.17%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
AHCO AdaptHealth
$23.85 /

-0.04 (-0.17%)

07/14/21 Baird
AdaptHealth upgraded to Outperform on increasing investor confidence at Baird
07/14/21 Baird
AdaptHealth upgraded to Outperform from Neutral at Baird
07/08/21 Jefferies
Medicare home oxygen proposal positive for AdaptHealth, says Jefferies
05/07/21 Canaccord
AdaptHealth price target lowered to $44 from $50 at Canaccord
ASMB Assembly Biosciences
$3.26 /

-0.055 (-1.66%)

09/13/21 H.C. Wainwright
Assembly Biosciences initiated with a Neutral at H.C. Wainwright
09/03/21 Mizuho
Assembly stopping H2158 development not necessarily bad thing, says Mizuho
09/02/21
Fly Intel: Top five analyst downgrades
09/02/21 William Blair
William Blair downgrades Assembly Biosciences on H2158 discontinuation
FATE Fate Therapeutics
$64.86 /

-0.95 (-1.44%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
STE Steris
$215.95 /

+5.59 (+2.66%)

08/11/21 KeyBanc
Steris price target raised to $239 from $227 at KeyBanc
08/11/21 Stephens
Steris price target raised to $255 from $217 at Stephens
08/11/21 Baird
Steris price target raised to $250 from $230 at Baird
05/26/21
Fly Intel: Top five analyst upgrades
IQV Iqvia
$257.63 /

+2.01 (+0.79%)

09/10/21 Argus
Iqvia price target raised to $290 from $260 at Argus
08/04/21 Credit Suisse
Iqvia assumed with an Outperform at Credit Suisse
07/28/21 Piper Sandler
Iqvia price target raised to $235 from $204 at Piper Sandler
07/28/21 Deutsche Bank
Iqvia price target raised to $250 from $244 at Deutsche Bank
IVC Invacare
$5.91 /

-0.62 (-9.49%)

09/10/21 Needham
Invacare price target lowered to $8 from $17 at Needham
08/19/21 Oppenheimer
Invacare initiated with an Outperform at Oppenheimer
ICPT Intercept
$15.15 /

+0.365 (+2.47%)

08/20/21
Fly Intel: Top five analyst downgrades
08/20/21 Goldman Sachs
Intercept downgraded to Sell from Neutral at Goldman Sachs
08/03/21 B. Riley
Intercept price target raised to $22 from $18 at B. Riley
08/02/21 Wedbush
Intercept price target lowered to $67 from $74 at Wedbush
HGEN Humanigen
$6.09 /

-0.155 (-2.48%)

09/10/21
Fly Intel: Top five analyst downgrades
09/10/21 Jefferies
Humanigen downgraded to Hold from Buy at Jefferies
09/09/21 Credit Suisse
Credit Suisse cuts Humanigen to Neutral after FDA denies lenzilumab EUA
09/09/21 Credit Suisse
Humanigen downgraded to Neutral from Outperform at Credit Suisse
GERN Geron
$1.33 /

-0.06 (-4.33%)

02/18/21 B. Riley
Geron transferred with Buy rating at B. Riley Securities
10/14/20 B. Riley
Geron shares have 100% potential upside, says B. Riley Securities
NTRA Natera
$120.16 /

-0.07 (-0.06%)

08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
08/06/21 Wells Fargo
Natera price target raised to $135 from $125 at Wells Fargo
08/06/21 Baird
Natera price target raised to $145 from $127 at Baird
JNCE Jounce Therapeutics
$7.26 /

+0.785 (+12.12%)

09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform with $10 target at Raymond James
09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform from Market Perform at Raymond James
08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
COO Cooper Companies
$441.45 /

+0.87 (+0.20%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
NOVT Novanta
$150.22 /

-2.125 (-1.39%)

11/13/20 Berenberg
Novanta initiated with a Hold at Berenberg
MYOV Myovant Sciences
$21.50 /

-1.28 (-5.62%)

09/09/21 SVB Leerink
SVB Leerink starts Myovant at Market Perform
09/09/21 SVB Leerink
Myovant Sciences initiated with a Market Perform at SVB Leerink
08/19/21 Goldman Sachs
Myovant Sciences assumed with a Neutral at Goldman Sachs
05/13/21 Citi
Myovant Sciences price target lowered to $24 from $30 at Citi
SRPT Sarepta
$80.18 /

-1.68 (-2.05%)

08/05/21 JPMorgan
Sarepta upgraded to Neutral after 60% selloff at JPMorgan
08/05/21 JPMorgan
Sarepta upgraded to Neutral from Underweight at JPMorgan
07/01/21 Berenberg
Sarepta assumed with a Hold at Berenberg
06/14/21 BTIG
Sarepta initiated with a Buy at BTIG
RCM R1 RCM
$20.24 /

-0.17 (-0.83%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 BofA
BofA starts R1 RCM at Buy, sees 32% upside potential
07/22/21 BofA
R1 RCM initiated with a Buy at BofA
06/02/21 Baird
R1 RCM initiated with an Outperform at Baird
XRAY Dentsply Sirona
$61.79 /

-0.05 (-0.08%)

08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/09/21 H.C. Wainwright
Dentsply Sirona price target lowered to $66 from $72 at H.C. Wainwright
08/06/21 Barrington
Dentsply Sirona price target raised to $79 from $77 at Barrington
08/06/21 Piper Sandler
Dentsply Sirona weakness a buying opportunity, says Piper Sandler
VIR Vir Biotechnology
$50.17 /

+0.17 (+0.34%)

06/03/21 Baird
Vir Biotechnology assumed with a Neutral at Baird
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
03/08/21 H.C. Wainwright
Vir Biotechnology price target raised to $135 from $125 at H.C. Wainwright
TNDM TNDM
/

+

08/05/21 SVB Leerink
Tandem Diabetes price target raised to $123 from $102 at SVB Leerink
08/05/21 Craig-Hallum
Tandem Diabetes price target raised to $153 from $140 at Craig-Hallum
08/05/21 Wells Fargo
Tandem Diabetes price target raised to $121 from $112 at Wells Fargo
08/05/21 Oppenheimer
Tandem Diabetes price target raised to $140 from $135 at Oppenheimer
TLMD SOC Telemed
$2.84 /

-0.07 (-2.41%)

09/01/21 Benchmark
SOC Telemed CEO change due to 'uneven' performance, says Benchmark
08/13/21 RBC Capital
SOC Telemed price target lowered to $6 from $10 at RBC Capital
08/13/21 Benchmark
SOC Telemed price target lowered to $7 from $10 at Benchmark
05/28/21 Baird
Baird starts 'uniquely well-positioned' SOC Telemed with an Outperform
TRHC Tabula Rasa HealthCare
$28.82 /

-0.92 (-3.09%)

06/03/21 Truist
Tabula Rasa HealthCare price target raised to $47 from $42 at Truist
05/28/21 Baird
Baird starts Tabula Rasa HealthCare with Outperform amid low expectations
05/27/21 Baird
Tabula Rasa HealthCare initiated with an Outperform at Baird
05/07/21 Piper Sandler
Tabula Rasa price target raised to $45 from $41 at Piper Sandler
ZBH Zimmer Biomet
$147.63 /

+6.69 (+4.75%)

09/14/21 Raymond James
Zimmer Biomet resumed with a Market Perform at Raymond James
08/30/21 Cowen
Zimmer Biomet approval 'kicks off' smart implant era in orthopedics, says Cowen
08/30/21 Piper Sandler
Piper says Persona IQ represents 'another exciting approval' for Zimmer Biomet
08/25/21 Citi
Citi adds Medtronic to Focus List, boosts price target
MRVL Marvell
$62.30 /

-0.09 (-0.14%)

08/27/21
Fly Intel: Top five analyst downgrades
08/27/21 Craig-Hallum
Marvell downgraded to Hold on valuation at Craig-Hallum
08/27/21 Craig-Hallum
Marvell downgraded to Hold from Buy at Craig-Hallum
08/27/21 B. Riley
Marvell earnings selloff brings 'enhanced entry point,' says B. Riley
TIL Instil Bio
$16.45 /

-1.28 (-7.22%)

08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
TECH Bio-Techne
$510.50 /

+8.11 (+1.61%)

09/15/21 KeyBanc
Bio-Techne upgraded to Overweight from Sector Weight at KeyBanc
08/24/21 Argus
Bio-Techne price target raised to $540 from $490 at Argus
08/06/21 Baird
Bio-Techne price target raised to $522 from $430 at Baird
08/05/21 Benchmark
Bio-Techne price target raised to $540 from $480 at Benchmark
TALK Talkspace
$4.71 /

-0.145 (-2.99%)

08/19/21 Citi
Talkspace initiated with a Buy at Citi
07/19/21 William Blair
Talkspace initiated with an Outperform at William Blair
07/08/21 Baird
Talkspace initiated with an Outperform at Baird
07/06/21 Cowen
Talkspace initiated with an Outperform at Cowen
ZBH Zimmer Biomet
$147.63 /

+6.69 (+4.75%)

XRAY Dentsply Sirona
$61.79 /

-0.05 (-0.08%)

VIR Vir Biotechnology
$50.17 /

+0.17 (+0.34%)

TRHC Tabula Rasa HealthCare
$28.82 /

-0.92 (-3.09%)

TNDM TNDM
/

+

TLMD SOC Telemed
$2.84 /

-0.07 (-2.41%)

TIL Instil Bio
$16.45 /

-1.28 (-7.22%)

TALK Talkspace
$4.71 /

-0.145 (-2.99%)

STE Steris
$215.95 /

+5.59 (+2.66%)

SRPT Sarepta
$80.18 /

-1.68 (-2.05%)

RCM R1 RCM
$20.24 /

-0.17 (-0.83%)

NTRA Natera
$120.16 /

-0.07 (-0.06%)

NOVT Novanta
$150.22 /

-2.125 (-1.39%)

MYOV Myovant Sciences
$21.50 /

-1.28 (-5.62%)

MRVL Marvell
$62.30 /

-0.09 (-0.14%)

JNCE Jounce Therapeutics
$7.26 /

+0.785 (+12.12%)

IVC Invacare
$5.91 /

-0.62 (-9.49%)

IQV Iqvia
$257.63 /

+2.01 (+0.79%)

ICPT Intercept
$15.15 /

+0.365 (+2.47%)

HGEN Humanigen
$6.09 /

-0.155 (-2.48%)

GERN Geron
$1.33 /

-0.06 (-4.33%)

FATE Fate Therapeutics
$64.86 /

-0.95 (-1.44%)

COO Cooper Companies
$441.45 /

+0.87 (+0.20%)

ASMB Assembly Biosciences
$3.26 /

-0.055 (-1.66%)

AHCO AdaptHealth
$23.85 /

-0.04 (-0.17%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

  • 22
    Jul
  • 27
    May
  • 27
    May
  • 31
    Mar
  • 19
    Mar
  • 10
    Mar
  • 06
    Jan
  • 06
    Jan
  • 15
    Dec
  • 18
    Sep
XRAY Dentsply Sirona
$61.79 /

-0.05 (-0.08%)

SRPT Sarepta
$80.18 /

-1.68 (-2.05%)

MRVL Marvell
$62.30 /

-0.09 (-0.14%)

ZBH Zimmer Biomet
$147.63 /

+6.69 (+4.75%)

VIR Vir Biotechnology
$50.17 /

+0.17 (+0.34%)

TLMD SOC Telemed
$2.84 /

-0.07 (-2.41%)

TIL Instil Bio
$16.45 /

-1.28 (-7.22%)

STE Steris
$215.95 /

+5.59 (+2.66%)

SRPT Sarepta
$80.18 /

-1.68 (-2.05%)

RCM R1 RCM
$20.24 /

-0.17 (-0.83%)

NTRA Natera
$120.16 /

-0.07 (-0.06%)

MYOV Myovant Sciences
$21.50 /

-1.28 (-5.62%)

MRVL Marvell
$62.30 /

-0.09 (-0.14%)

IVC Invacare
$5.91 /

-0.62 (-9.49%)

ICPT Intercept
$15.15 /

+0.365 (+2.47%)

HGEN Humanigen
$6.09 /

-0.155 (-2.48%)

GERN Geron
$1.33 /

-0.06 (-4.33%)

FATE Fate Therapeutics
$64.86 /

-0.95 (-1.44%)

AHCO AdaptHealth
$23.85 /

-0.04 (-0.17%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

TALK Talkspace
$4.71 /

-0.145 (-2.99%)

STE Steris
$215.95 /

+5.59 (+2.66%)

MRVL Marvell
$62.30 /

-0.09 (-0.14%)

HGEN Humanigen
$6.09 /

-0.155 (-2.48%)

GERN Geron
$1.33 /

-0.06 (-4.33%)

COO Cooper Companies
$441.45 /

+0.87 (+0.20%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

Tuesday
Conference/Events
Robert W. Baird & Co. to hold a virtual conference » 10:00
09/14/21
09/14
10:00
09/14/21
10:00
ABUS

Arbutus Biopharma

$4.22 /

-0.035 (-0.82%)

, AHCO

AdaptHealth

$24.25 /

+0.36 (+1.51%)

, ASMB

Assembly Biosciences

$3.30 /

-0.01 (-0.30%)

, FATE

Fate Therapeutics

$66.74 /

+0.93 (+1.41%)

, STE

Steris

$211.52 /

+1.16 (+0.55%)

, IQV

Iqvia

$258.35 /

+2.73 (+1.07%)

, IVC

Invacare

$6.95 /

+0.42 (+6.43%)

, ICPT

Intercept

$14.66 /

-0.125 (-0.85%)

, HGEN

Humanigen

$6.35 /

+0.11 (+1.76%)

, GERN

Geron

$1.38 /

-0.01 (-0.72%)

, NTRA

Natera

$122.38 /

+2.15 (+1.79%)

, JNCE

Jounce Therapeutics

$7.23 /

+0.755 (+11.66%)

, COO

Cooper Companies

$442.66 /

+2.08 (+0.47%)

, NOVT

Novanta

$151.80 /

-0.545 (-0.36%)

, MYOV

Myovant Sciences

$22.85 /

+0.07 (+0.31%)

, SRPT

Sarepta

$81.79 /

-0.07 (-0.09%)

, RCM

R1 RCM

$20.47 /

+0.06 (+0.29%)

, XRAY

Dentsply Sirona

$62.66 /

+0.82 (+1.33%)

, VIR

Vir Biotechnology

$51.51 /

+1.51 (+3.02%)

, TNDM

TNDM

/

+

, TLMD

SOC Telemed

$2.97 /

+0.065 (+2.24%)

, TRHC

Tabula Rasa HealthCare

$29.76 /

+0.02 (+0.07%)

, ZBH

Zimmer Biomet

$140.76 /

-0.18 (-0.13%)

, MRVL

Marvell

$62.64 /

+0.25 (+0.40%)

, TIL

Instil Bio

$18.57 /

+0.84 (+4.74%)

, TECH

Bio-Techne

$510.21 /

+7.82 (+1.56%)

, TALK

Talkspace

$4.84 /

-0.015 (-0.31%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on September 14-15.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$140.76 /

-0.18 (-0.13%)

XRAY Dentsply Sirona
$62.66 /

+0.82 (+1.33%)

VIR Vir Biotechnology
$51.51 /

+1.51 (+3.02%)

TRHC Tabula Rasa HealthCare
$29.76 /

+0.02 (+0.07%)

TNDM TNDM
/

+

TLMD SOC Telemed
$2.97 /

+0.065 (+2.24%)

TIL Instil Bio
$18.57 /

+0.84 (+4.74%)

TECH Bio-Techne
$510.21 /

+7.82 (+1.56%)

TALK Talkspace
$4.84 /

-0.015 (-0.31%)

STE Steris
$211.52 /

+1.16 (+0.55%)

SRPT Sarepta
$81.79 /

-0.07 (-0.09%)

RCM R1 RCM
$20.47 /

+0.06 (+0.29%)

NTRA Natera
$122.38 /

+2.15 (+1.79%)

NOVT Novanta
$151.80 /

-0.545 (-0.36%)

MYOV Myovant Sciences
$22.85 /

+0.07 (+0.31%)

MRVL Marvell
$62.64 /

+0.25 (+0.40%)

JNCE Jounce Therapeutics
$7.23 /

+0.755 (+11.66%)

IVC Invacare
$6.95 /

+0.42 (+6.43%)

IQV Iqvia
$258.35 /

+2.73 (+1.07%)

ICPT Intercept
$14.66 /

-0.125 (-0.85%)

HGEN Humanigen
$6.35 /

+0.11 (+1.76%)

GERN Geron
$1.38 /

-0.01 (-0.72%)

FATE Fate Therapeutics
$66.74 /

+0.93 (+1.41%)

COO Cooper Companies
$442.66 /

+2.08 (+0.47%)

ASMB Assembly Biosciences
$3.30 /

-0.01 (-0.30%)

AHCO AdaptHealth
$24.25 /

+0.36 (+1.51%)

ABUS Arbutus Biopharma
$4.22 /

-0.035 (-0.82%)

ABUS Arbutus Biopharma
$4.22 /

-0.035 (-0.82%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
AHCO AdaptHealth
$24.25 /

+0.36 (+1.51%)

07/14/21 Baird
AdaptHealth upgraded to Outperform on increasing investor confidence at Baird
07/14/21 Baird
AdaptHealth upgraded to Outperform from Neutral at Baird
07/08/21 Jefferies
Medicare home oxygen proposal positive for AdaptHealth, says Jefferies
05/07/21 Canaccord
AdaptHealth price target lowered to $44 from $50 at Canaccord
ASMB Assembly Biosciences
$3.30 /

-0.01 (-0.30%)

09/13/21 H.C. Wainwright
Assembly Biosciences initiated with a Neutral at H.C. Wainwright
09/03/21 Mizuho
Assembly stopping H2158 development not necessarily bad thing, says Mizuho
09/02/21
Fly Intel: Top five analyst downgrades
09/02/21 William Blair
William Blair downgrades Assembly Biosciences on H2158 discontinuation
FATE Fate Therapeutics
$66.74 /

+0.93 (+1.41%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
STE Steris
$211.52 /

+1.16 (+0.55%)

08/11/21 KeyBanc
Steris price target raised to $239 from $227 at KeyBanc
08/11/21 Stephens
Steris price target raised to $255 from $217 at Stephens
08/11/21 Baird
Steris price target raised to $250 from $230 at Baird
05/26/21
Fly Intel: Top five analyst upgrades
IQV Iqvia
$258.35 /

+2.73 (+1.07%)

09/10/21 Argus
Iqvia price target raised to $290 from $260 at Argus
08/04/21 Credit Suisse
Iqvia assumed with an Outperform at Credit Suisse
07/28/21 Piper Sandler
Iqvia price target raised to $235 from $204 at Piper Sandler
07/28/21 Deutsche Bank
Iqvia price target raised to $250 from $244 at Deutsche Bank
IVC Invacare
$6.95 /

+0.42 (+6.43%)

09/10/21 Needham
Invacare price target lowered to $8 from $17 at Needham
08/19/21 Oppenheimer
Invacare initiated with an Outperform at Oppenheimer
ICPT Intercept
$14.66 /

-0.125 (-0.85%)

08/20/21
Fly Intel: Top five analyst downgrades
08/20/21 Goldman Sachs
Intercept downgraded to Sell from Neutral at Goldman Sachs
08/03/21 B. Riley
Intercept price target raised to $22 from $18 at B. Riley
08/02/21 Wedbush
Intercept price target lowered to $67 from $74 at Wedbush
HGEN Humanigen
$6.35 /

+0.11 (+1.76%)

09/10/21
Fly Intel: Top five analyst downgrades
09/10/21 Jefferies
Humanigen downgraded to Hold from Buy at Jefferies
09/09/21 Credit Suisse
Credit Suisse cuts Humanigen to Neutral after FDA denies lenzilumab EUA
09/09/21 Credit Suisse
Humanigen downgraded to Neutral from Outperform at Credit Suisse
GERN Geron
$1.38 /

-0.01 (-0.72%)

02/18/21 B. Riley
Geron transferred with Buy rating at B. Riley Securities
10/14/20 B. Riley
Geron shares have 100% potential upside, says B. Riley Securities
NTRA Natera
$122.38 /

+2.15 (+1.79%)

08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
08/09/21 Piper Sandler
Natera price target raised to $160 from $155 at Piper Sandler
08/06/21 Wells Fargo
Natera price target raised to $135 from $125 at Wells Fargo
08/06/21 Baird
Natera price target raised to $145 from $127 at Baird
JNCE Jounce Therapeutics
$7.23 /

+0.755 (+11.66%)

09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform with $10 target at Raymond James
09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform from Market Perform at Raymond James
08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
COO Cooper Companies
$442.66 /

+2.08 (+0.47%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
NOVT Novanta
$151.80 /

-0.545 (-0.36%)

11/13/20 Berenberg
Novanta initiated with a Hold at Berenberg
MYOV Myovant Sciences
$22.85 /

+0.07 (+0.31%)

09/09/21 SVB Leerink
SVB Leerink starts Myovant at Market Perform
09/09/21 SVB Leerink
Myovant Sciences initiated with a Market Perform at SVB Leerink
08/19/21 Goldman Sachs
Myovant Sciences assumed with a Neutral at Goldman Sachs
05/13/21 Citi
Myovant Sciences price target lowered to $24 from $30 at Citi
SRPT Sarepta
$81.79 /

-0.07 (-0.09%)

08/05/21 JPMorgan
Sarepta upgraded to Neutral after 60% selloff at JPMorgan
08/05/21 JPMorgan
Sarepta upgraded to Neutral from Underweight at JPMorgan
07/01/21 Berenberg
Sarepta assumed with a Hold at Berenberg
06/14/21 BTIG
Sarepta initiated with a Buy at BTIG
RCM R1 RCM
$20.47 /

+0.06 (+0.29%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 BofA
BofA starts R1 RCM at Buy, sees 32% upside potential
07/22/21 BofA
R1 RCM initiated with a Buy at BofA
06/02/21 Baird
R1 RCM initiated with an Outperform at Baird
XRAY Dentsply Sirona
$62.66 /

+0.82 (+1.33%)

08/10/21 Goldman Sachs
SmileDirectClub price target lowered to $4 from $7 at Goldman Sachs
08/09/21 H.C. Wainwright
Dentsply Sirona price target lowered to $66 from $72 at H.C. Wainwright
08/06/21 Barrington
Dentsply Sirona price target raised to $79 from $77 at Barrington
08/06/21 Piper Sandler
Dentsply Sirona weakness a buying opportunity, says Piper Sandler
VIR Vir Biotechnology
$51.51 /

+1.51 (+3.02%)

06/03/21 Baird
Vir Biotechnology assumed with a Neutral at Baird
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
03/11/21 Needham
Vir Biotechnology price target raised to $80 from $75 at Needham
03/08/21 H.C. Wainwright
Vir Biotechnology price target raised to $135 from $125 at H.C. Wainwright
TNDM TNDM
/

+

08/05/21 SVB Leerink
Tandem Diabetes price target raised to $123 from $102 at SVB Leerink
08/05/21 Craig-Hallum
Tandem Diabetes price target raised to $153 from $140 at Craig-Hallum
08/05/21 Wells Fargo
Tandem Diabetes price target raised to $121 from $112 at Wells Fargo
08/05/21 Oppenheimer
Tandem Diabetes price target raised to $140 from $135 at Oppenheimer
TLMD SOC Telemed
$2.97 /

+0.065 (+2.24%)

09/01/21 Benchmark
SOC Telemed CEO change due to 'uneven' performance, says Benchmark
08/13/21 RBC Capital
SOC Telemed price target lowered to $6 from $10 at RBC Capital
08/13/21 Benchmark
SOC Telemed price target lowered to $7 from $10 at Benchmark
05/28/21 Baird
Baird starts 'uniquely well-positioned' SOC Telemed with an Outperform
TRHC Tabula Rasa HealthCare
$29.76 /

+0.02 (+0.07%)

06/03/21 Truist
Tabula Rasa HealthCare price target raised to $47 from $42 at Truist
05/28/21 Baird
Baird starts Tabula Rasa HealthCare with Outperform amid low expectations
05/27/21 Baird
Tabula Rasa HealthCare initiated with an Outperform at Baird
05/07/21 Piper Sandler
Tabula Rasa price target raised to $45 from $41 at Piper Sandler
ZBH Zimmer Biomet
$140.76 /

-0.18 (-0.13%)

09/14/21 Raymond James
Zimmer Biomet resumed with a Market Perform at Raymond James
08/30/21 Cowen
Zimmer Biomet approval 'kicks off' smart implant era in orthopedics, says Cowen
08/30/21 Piper Sandler
Piper says Persona IQ represents 'another exciting approval' for Zimmer Biomet
08/25/21 Citi
Citi adds Medtronic to Focus List, boosts price target
MRVL Marvell
$62.64 /

+0.25 (+0.40%)

08/27/21
Fly Intel: Top five analyst downgrades
08/27/21 Craig-Hallum
Marvell downgraded to Hold on valuation at Craig-Hallum
08/27/21 Craig-Hallum
Marvell downgraded to Hold from Buy at Craig-Hallum
08/27/21 B. Riley
Marvell earnings selloff brings 'enhanced entry point,' says B. Riley
TIL Instil Bio
$18.57 /

+0.84 (+4.74%)

08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
TECH Bio-Techne
$510.21 /

+7.82 (+1.56%)

08/24/21 Argus
Bio-Techne price target raised to $540 from $490 at Argus
08/06/21 Baird
Bio-Techne price target raised to $522 from $430 at Baird
08/05/21 Benchmark
Bio-Techne price target raised to $540 from $480 at Benchmark
06/18/21 Argus
Bio-Techne price target raised to $490 from $440 at Argus
TALK Talkspace
$4.84 /

-0.015 (-0.31%)

08/19/21 Citi
Talkspace initiated with a Buy at Citi
07/19/21 William Blair
Talkspace initiated with an Outperform at William Blair
07/08/21 Baird
Talkspace initiated with an Outperform at Baird
07/06/21 Cowen
Talkspace initiated with an Outperform at Cowen
ZBH Zimmer Biomet
$140.76 /

-0.18 (-0.13%)

XRAY Dentsply Sirona
$62.66 /

+0.82 (+1.33%)

VIR Vir Biotechnology
$51.51 /

+1.51 (+3.02%)

TRHC Tabula Rasa HealthCare
$29.76 /

+0.02 (+0.07%)

TNDM TNDM
/

+

TLMD SOC Telemed
$2.97 /

+0.065 (+2.24%)

TIL Instil Bio
$18.57 /

+0.84 (+4.74%)

TALK Talkspace
$4.84 /

-0.015 (-0.31%)

STE Steris
$211.52 /

+1.16 (+0.55%)

SRPT Sarepta
$81.79 /

-0.07 (-0.09%)

RCM R1 RCM
$20.47 /

+0.06 (+0.29%)

NTRA Natera
$122.38 /

+2.15 (+1.79%)

NOVT Novanta
$151.80 /

-0.545 (-0.36%)

MYOV Myovant Sciences
$22.85 /

+0.07 (+0.31%)

MRVL Marvell
$62.64 /

+0.25 (+0.40%)

JNCE Jounce Therapeutics
$7.23 /

+0.755 (+11.66%)

IVC Invacare
$6.95 /

+0.42 (+6.43%)

IQV Iqvia
$258.35 /

+2.73 (+1.07%)

ICPT Intercept
$14.66 /

-0.125 (-0.85%)

HGEN Humanigen
$6.35 /

+0.11 (+1.76%)

GERN Geron
$1.38 /

-0.01 (-0.72%)

FATE Fate Therapeutics
$66.74 /

+0.93 (+1.41%)

COO Cooper Companies
$442.66 /

+2.08 (+0.47%)

ASMB Assembly Biosciences
$3.30 /

-0.01 (-0.30%)

AHCO AdaptHealth
$24.25 /

+0.36 (+1.51%)

ABUS Arbutus Biopharma
$4.22 /

-0.035 (-0.82%)

  • 22
    Jul
  • 27
    May
  • 27
    May
  • 31
    Mar
  • 19
    Mar
  • 10
    Mar
  • 06
    Jan
  • 06
    Jan
  • 15
    Dec
  • 18
    Sep
XRAY Dentsply Sirona
$62.66 /

+0.82 (+1.33%)

SRPT Sarepta
$81.79 /

-0.07 (-0.09%)

MRVL Marvell
$62.64 /

+0.25 (+0.40%)

ZBH Zimmer Biomet
$140.76 /

-0.18 (-0.13%)

VIR Vir Biotechnology
$51.51 /

+1.51 (+3.02%)

TLMD SOC Telemed
$2.97 /

+0.065 (+2.24%)

TIL Instil Bio
$18.57 /

+0.84 (+4.74%)

STE Steris
$211.52 /

+1.16 (+0.55%)

SRPT Sarepta
$81.79 /

-0.07 (-0.09%)

RCM R1 RCM
$20.47 /

+0.06 (+0.29%)

NTRA Natera
$122.38 /

+2.15 (+1.79%)

MYOV Myovant Sciences
$22.85 /

+0.07 (+0.31%)

MRVL Marvell
$62.64 /

+0.25 (+0.40%)

IVC Invacare
$6.95 /

+0.42 (+6.43%)

ICPT Intercept
$14.66 /

-0.125 (-0.85%)

HGEN Humanigen
$6.35 /

+0.11 (+1.76%)

GERN Geron
$1.38 /

-0.01 (-0.72%)

FATE Fate Therapeutics
$66.74 /

+0.93 (+1.41%)

AHCO AdaptHealth
$24.25 /

+0.36 (+1.51%)

ABUS Arbutus Biopharma
$4.22 /

-0.035 (-0.82%)

TALK Talkspace
$4.84 /

-0.015 (-0.31%)

STE Steris
$211.52 /

+1.16 (+0.55%)

MRVL Marvell
$62.64 /

+0.25 (+0.40%)

HGEN Humanigen
$6.35 /

+0.11 (+1.76%)

GERN Geron
$1.38 /

-0.01 (-0.72%)

COO Cooper Companies
$442.66 /

+2.08 (+0.47%)

ABUS Arbutus Biopharma
$4.22 /

-0.035 (-0.82%)

Upgrade
Jounce Therapeutics upgraded to Outperform with $10 target at Raymond James » 05:31
09/14/21
09/14
05:31
09/14/21
05:31
JNCE

Jounce Therapeutics

$6.48 /

+0.12 (+1.89%)

Raymond James analyst…

Raymond James analyst Steven Seedhouse upgraded Jounce Therapeutics to Outperform from Market Perform with a $10 price target. The analyst added JTX-8064 to his model following a look into the leukocyte immunoglobulin-like receptors competitive landscape. Recent macrophage-targeted immuno-oncology deal activity "suggest plenty of strategic interest," Seedhouse tells investors in a research note. He believes Merck's (MRK) MK-4830's expansion cohort data in the first half of 2022 is the "major catalyst to watch which could further catalyze interest and value creation in this space."

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$6.48 /

+0.12 (+1.89%)

JNCE Jounce Therapeutics
$6.48 /

+0.12 (+1.89%)

09/14/21 Raymond James
Jounce Therapeutics upgraded to Outperform from Market Perform at Raymond James
08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
JNCE Jounce Therapeutics
$6.48 /

+0.12 (+1.89%)

  • 10
    Mar
Upgrade
Jounce Therapeutics upgraded to Outperform from Market Perform at Raymond James » 05:22
09/14/21
09/14
05:22
09/14/21
05:22
JNCE

Jounce Therapeutics

$6.48 /

+0.12 (+1.89%)

Raymond James analyst…

Raymond James analyst Steven Seedhouse upgraded Jounce Therapeutics to Outperform from Market Perform with a $10 price target.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$6.48 /

+0.12 (+1.89%)

JNCE Jounce Therapeutics
$6.48 /

+0.12 (+1.89%)

08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
JNCE Jounce Therapeutics
$6.48 /

+0.12 (+1.89%)

  • 10
    Mar
Over a week ago
Conference/Events
Wells Fargo to hold a virtual conference » 04:55
09/10/21
09/10
04:55
09/10/21
04:55
A

Agilent

$177.24 /

-1.54 (-0.86%)

, ABT

Abbott

$127.96 /

-1.11 (-0.86%)

, ARCT

Arcturus Therapeutics

$55.80 /

+0.2 (+0.36%)

, COO

Cooper Companies

$448.62 /

-5.5 (-1.21%)

, EXAS

Exact Sciences

$105.82 /

+2.35 (+2.27%)

, FATE

Fate Therapeutics

$69.31 /

-0.21 (-0.30%)

, FLXN

Flexion

$6.42 /

-0.01 (-0.16%)

, GBT

Global Blood Therapeutics

$30.15 /

+0.14 (+0.47%)

, JNCE

Jounce Therapeutics

$6.61 /

+0.1 (+1.54%)

, JNJ

Johnson & Johnson

$167.94 /

-3.94 (-2.29%)

, KRTX

Karuna Therapeutics

$117.75 /

+0.83 (+0.71%)

, KZR

Kezar Life Sciences

$7.90 /

+0.1 (+1.28%)

, LNTH

Lantheus

$26.17 /

+0.02 (+0.08%)

, MDWD

MediWound

$3.76 /

-0.09 (-2.34%)

, MDT

Medtronic

$133.42 /

-1.715 (-1.27%)

, PACB

Pacific Biosciences

$30.01 /

+0.61 (+2.07%)

, TPTX

Turning Point Therapeutics

$77.37 /

-0.79 (-1.01%)

, SCI

Service Corp.

$62.47 /

-0.99 (-1.56%)

, SMFR

Sema4 Holdings

$8.91 /

+0.23 (+2.65%)

, SGMO

Sangamo

$9.95 /

+0.12 (+1.22%)

, RVNC

Revance

$27.86 /

+0.56 (+2.05%)

, TFX

Teleflex

$385.37 /

-14.73 (-3.68%)

, TECH

Bio-Techne

$507.81 /

+0.92 (+0.18%)

, TSHA

Taysha Gene Therapies

$20.12 /

+0.27 (+1.36%)

, TNDM

TNDM

/

+

, RAPT

Rapt Therapeutics

$36.26 /

+0.2 (+0.55%)

, QURE

uniQure

$35.41 /

+0.73 (+2.10%)

, NVTA

Invitae

$31.73 /

+0.56 (+1.80%)

, ITOS

iTeos Therapeutics

$28.71 /

+0.4 (+1.41%)

, ISRG

Intuitive Surgical

$1,070.49 /

-10.51 (-0.97%)

2021 Wells Fargo…

2021 Wells Fargo Healthcare Virtual Conference to be held on September 9-10.Webcast Link

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

TPTX Turning Point Therapeutics
$77.37 /

-0.79 (-1.01%)

TNDM TNDM
/

+

TFX Teleflex
$385.37 /

-14.73 (-3.68%)

TECH Bio-Techne
$507.81 /

+0.92 (+0.18%)

SMFR Sema4 Holdings
$8.91 /

+0.23 (+2.65%)

SGMO Sangamo
$9.95 /

+0.12 (+1.22%)

SCI Service Corp.
$62.47 /

-0.99 (-1.56%)

RVNC Revance
$27.86 /

+0.56 (+2.05%)

RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

PACB Pacific Biosciences
$30.01 /

+0.61 (+2.07%)

NVTA Invitae
$31.73 /

+0.56 (+1.80%)

MDWD MediWound
$3.76 /

-0.09 (-2.34%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

LNTH Lantheus
$26.17 /

+0.02 (+0.08%)

KZR Kezar Life Sciences
$7.90 /

+0.1 (+1.28%)

KRTX Karuna Therapeutics
$117.75 /

+0.83 (+0.71%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

JNCE Jounce Therapeutics
$6.61 /

+0.1 (+1.54%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

GBT Global Blood Therapeutics
$30.15 /

+0.14 (+0.47%)

FLXN Flexion
$6.42 /

-0.01 (-0.16%)

FATE Fate Therapeutics
$69.31 /

-0.21 (-0.30%)

EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

COO Cooper Companies
$448.62 /

-5.5 (-1.21%)

ARCT Arcturus Therapeutics
$55.80 /

+0.2 (+0.36%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

08/18/21 SVB Leerink
Agilent price target raised to $170 from $160 at SVB Leerink
08/18/21 Cowen
Agilent price target raised to $165 from $150 at Cowen
08/18/21 Jefferies
Agilent price target raised to $185 from $155 at Jefferies
08/18/21 KeyBanc
Agilent price target raised to $195 from $160 at KeyBanc
ABT Abbott
$127.96 /

-1.11 (-0.86%)

08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
08/31/21 Barclays
Abbott's Amulet could become 'needle mover,' says Barclays
08/30/21 Piper Sandler
Boston Scientific's Watchman still well positioned, says Piper Sandler
08/23/21 Cowen
Abbott price target raised to $140 from $125 at Cowen
ARCT Arcturus Therapeutics
$55.80 /

+0.2 (+0.36%)

08/25/21 Citi
Arcturus Therapeutics price target lowered to $114 from $118 at Citi
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
COO Cooper Companies
$448.62 /

-5.5 (-1.21%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
08/03/21 Evercore ISI
Exact Sciences weakness 'exaggerated' after CFO's 10b5 sale, says Evercore ISI
07/29/21 Canaccord
Exact Sciences price target lowered to $160 from $185 at Canaccord
07/29/21 Oppenheimer
Exact Sciences price target lowered to $155 from $161 at Oppenheimer
FATE Fate Therapeutics
$69.31 /

-0.21 (-0.30%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
FLXN Flexion
$6.42 /

-0.01 (-0.16%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
GBT Global Blood Therapeutics
$30.15 /

+0.14 (+0.47%)

08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Piper Sandler
Global Blood price target lowered to $40 from $45 at Piper Sandler
JNCE Jounce Therapeutics
$6.61 /

+0.1 (+1.54%)

08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
09/07/21 Morgan Stanley
Johnson & Johnson downgraded to Equal Weight from Overweight at Morgan Stanley
KRTX Karuna Therapeutics
$117.75 /

+0.83 (+0.71%)

08/30/21 Citi
Karuna Therapeutics initiated with a Buy at Citi
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
KZR Kezar Life Sciences
$7.90 /

+0.1 (+1.28%)

07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
LNTH Lantheus
$26.17 /

+0.02 (+0.08%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
MDWD MediWound
$3.76 /

-0.09 (-2.34%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
MDT Medtronic
$133.42 /

-1.715 (-1.27%)

08/27/21 Argus
Medtronic price target raised to $165 from $150 at Argus
08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
08/25/21 Wells Fargo
Medtronic price target raised to $151 from $140 at Wells Fargo
PACB Pacific Biosciences
$30.01 /

+0.61 (+2.07%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
TPTX Turning Point Therapeutics
$77.37 /

-0.79 (-1.01%)

05/06/21 Roth Capital
Turning Point 'significantly undervalued' with catalysts ahead, says Roth
04/13/21 Roth Capital
Turning Point combo data show 'expansive pipeline potential,' says Roth Capital
04/06/21 Roth Capital
Turning Point price target raised to $175 from $170 at Roth Capital
03/02/21 Roth Capital
Turning Point has 'many value-driving catalysts' in 2021, says Roth Capital
SCI Service Corp.
$62.47 /

-0.99 (-1.56%)

05/10/21 Oppenheimer
Service Corp. price target raised to $59 from $54 at Oppenheimer
11/02/20 Credit Suisse
Service Corp. price target raised to $55 from $50 at Credit Suisse
SMFR Sema4 Holdings
$8.91 /

+0.23 (+2.65%)

SGMO Sangamo
$9.95 /

+0.12 (+1.22%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RVNC Revance
$27.86 /

+0.56 (+2.05%)

05/11/21 Mizuho
Revance price target lowered to $36 from $37 at Mizuho
04/23/21 Mizuho
Revance price target raised to $37 from $33 at Mizuho
02/23/21 Mizuho
Revance price target raised to $33 from $30 at Mizuho
02/23/21 H.C. Wainwright
Revance price target raised to $35 from $33 at H.C. Wainwright
TFX Teleflex
$385.37 /

-14.73 (-3.68%)

09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
08/02/21 KeyBanc
Teleflex price target lowered to $439 from $448 at KeyBanc
07/19/21 SVB Leerink
Teleflex downgraded to Market Perform from Outperform at SVB Leerink
07/15/21 Piper Sandler
Teleflex, Itamar pullbacks on proposed rate cuts overdone, says Piper Sandler
TECH Bio-Techne
$507.81 /

+0.92 (+0.18%)

08/24/21 Argus
Bio-Techne price target raised to $540 from $490 at Argus
08/06/21 Baird
Bio-Techne price target raised to $522 from $430 at Baird
08/05/21 Benchmark
Bio-Techne price target raised to $540 from $480 at Benchmark
06/18/21 Argus
Bio-Techne price target raised to $490 from $440 at Argus
TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
TNDM TNDM
/

+

08/05/21 SVB Leerink
Tandem Diabetes price target raised to $123 from $102 at SVB Leerink
08/05/21 Craig-Hallum
Tandem Diabetes price target raised to $153 from $140 at Craig-Hallum
08/05/21 Wells Fargo
Tandem Diabetes price target raised to $121 from $112 at Wells Fargo
08/05/21 Oppenheimer
Tandem Diabetes price target raised to $140 from $135 at Oppenheimer
RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

08/12/21 SVB Leerink
Rapt Therapeutics initiated with an Outperform at SVB Leerink
07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
06/23/21 H.C. Wainwright
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright
QURE uniQure
$35.41 /

+0.73 (+2.10%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
NVTA Invitae
$31.73 /

+0.56 (+1.80%)

08/04/21 Benchmark
Invitae upgraded to Buy from Hold at Benchmark
06/21/21 Wells Fargo
Invitae price target raised to $35 from $30 at Wells Fargo
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

07/22/21 Deutsche Bank
Intuitive Surgical price target raised to $925 from $825 at Deutsche Bank
07/21/21 SVB Leerink
Intuitive Surgical price target raised to $975 from $930 at SVB Leerink
07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
07/21/21 Wells Fargo
Intuitive Surgical price target raised to $1,060 from $916 at Wells Fargo
TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

TPTX Turning Point Therapeutics
$77.37 /

-0.79 (-1.01%)

TNDM TNDM
/

+

TFX Teleflex
$385.37 /

-14.73 (-3.68%)

SGMO Sangamo
$9.95 /

+0.12 (+1.22%)

SCI Service Corp.
$62.47 /

-0.99 (-1.56%)

RVNC Revance
$27.86 /

+0.56 (+2.05%)

RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

PACB Pacific Biosciences
$30.01 /

+0.61 (+2.07%)

NVTA Invitae
$31.73 /

+0.56 (+1.80%)

MDWD MediWound
$3.76 /

-0.09 (-2.34%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

LNTH Lantheus
$26.17 /

+0.02 (+0.08%)

KZR Kezar Life Sciences
$7.90 /

+0.1 (+1.28%)

KRTX Karuna Therapeutics
$117.75 /

+0.83 (+0.71%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

JNCE Jounce Therapeutics
$6.61 /

+0.1 (+1.54%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

GBT Global Blood Therapeutics
$30.15 /

+0.14 (+0.47%)

FLXN Flexion
$6.42 /

-0.01 (-0.16%)

FATE Fate Therapeutics
$69.31 /

-0.21 (-0.30%)

EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

COO Cooper Companies
$448.62 /

-5.5 (-1.21%)

ARCT Arcturus Therapeutics
$55.80 /

+0.2 (+0.36%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

  • 16
    Jun
  • 10
    Mar
  • 02
    Mar
  • 22
    Jan
  • 06
    Jan
  • 08
    Dec
  • 11
    Nov
  • 27
    Oct
  • 24
    Sep
NVTA Invitae
$31.73 /

+0.56 (+1.80%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

TPTX Turning Point Therapeutics
$77.37 /

-0.79 (-1.01%)

RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

MDWD MediWound
$3.76 /

-0.09 (-2.34%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

LNTH Lantheus
$26.17 /

+0.02 (+0.08%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

GBT Global Blood Therapeutics
$30.15 /

+0.14 (+0.47%)

FLXN Flexion
$6.42 /

-0.01 (-0.16%)

FATE Fate Therapeutics
$69.31 /

-0.21 (-0.30%)

EXAS Exact Sciences
$105.82 /

+2.35 (+2.27%)

ARCT Arcturus Therapeutics
$55.80 /

+0.2 (+0.36%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

SMFR Sema4 Holdings
$8.91 /

+0.23 (+2.65%)

RAPT Rapt Therapeutics
$36.26 /

+0.2 (+0.55%)

PACB Pacific Biosciences
$30.01 /

+0.61 (+2.07%)

NVTA Invitae
$31.73 /

+0.56 (+1.80%)

MDWD MediWound
$3.76 /

-0.09 (-2.34%)

MDT Medtronic
$133.42 /

-1.715 (-1.27%)

JNJ Johnson & Johnson
$167.94 /

-3.94 (-2.29%)

ITOS iTeos Therapeutics
$28.71 /

+0.4 (+1.41%)

ISRG Intuitive Surgical
$1,070.49 /

-10.51 (-0.97%)

COO Cooper Companies
$448.62 /

-5.5 (-1.21%)

ABT Abbott
$127.96 /

-1.11 (-0.86%)

A Agilent
$177.24 /

-1.54 (-0.86%)

Conference/Events
Wells Fargo to hold a virtual conference » 04:55
09/09/21
09/09
04:55
09/09/21
04:55
A

Agilent

$178.68 /

+0.93 (+0.52%)

, ABT

Abbott

$129.07 /

+0.7 (+0.55%)

, ARCT

Arcturus Therapeutics

$55.52 /

-1.03 (-1.82%)

, COO

Cooper Companies

$454.12 /

+6.85 (+1.53%)

, EXAS

Exact Sciences

$103.47 /

-1.52 (-1.45%)

, FATE

Fate Therapeutics

$69.52 /

-3.57 (-4.88%)

, FLXN

Flexion

$6.44 /

+0.165 (+2.63%)

, GBT

Global Blood Therapeutics

$30.01 /

+0.23 (+0.77%)

, JNCE

Jounce Therapeutics

$6.51 /

+0.015 (+0.23%)

, JNJ

Johnson & Johnson

$171.88 /

-0.41 (-0.24%)

, KRTX

Karuna Therapeutics

$116.74 /

-4.93 (-4.05%)

, KZR

Kezar Life Sciences

$7.79 /

-0.03 (-0.38%)

, LNTH

Lantheus

$26.17 /

+0.06 (+0.23%)

, MDWD

MediWound

$3.85 /

-0.07 (-1.79%)

, MDT

Medtronic

$135.13 /

+0.57 (+0.42%)

, PACB

Pacific Biosciences

$29.40 /

-0.9 (-2.97%)

, TPTX

Turning Point Therapeutics

$78.16 /

-1.32 (-1.66%)

, SCI

Service Corp.

$63.46 /

+0.825 (+1.32%)

, SMFR

Sema4 Holdings

$8.68 /

-0.55 (-5.96%)

, SGMO

Sangamo

$9.83 /

-0.19 (-1.90%)

, RVNC

Revance

$27.35 /

+0.06 (+0.22%)

, TFX

Teleflex

$400.07 /

+1.03 (+0.26%)

, TECH

Bio-Techne

$507.70 /

-6.81 (-1.32%)

, TSHA

Taysha Gene Therapies

$19.76 /

-1.81 (-8.39%)

, TNDM

TNDM

/

+

, RAPT

Rapt Therapeutics

$36.06 /

-0.14 (-0.39%)

, QURE

uniQure

$34.68 /

-0.24 (-0.69%)

, NVTA

Invitae

$31.17 /

-0.545 (-1.72%)

, ITOS

iTeos Therapeutics

$28.26 /

-0.88 (-3.02%)

, ISRG

Intuitive Surgical

$1,082.15 /

+4.97 (+0.46%)

2021 Wells Fargo…

2021 Wells Fargo Healthcare Virtual Conference to be held on September 9-10.Webcast Link

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

TNDM TNDM
/

+

TFX Teleflex
$400.07 /

+1.03 (+0.26%)

TECH Bio-Techne
$507.70 /

-6.81 (-1.32%)

SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

RVNC Revance
$27.35 /

+0.06 (+0.22%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

A Agilent
$178.68 /

+0.93 (+0.52%)

08/18/21 SVB Leerink
Agilent price target raised to $170 from $160 at SVB Leerink
08/18/21 Cowen
Agilent price target raised to $165 from $150 at Cowen
08/18/21 Jefferies
Agilent price target raised to $185 from $155 at Jefferies
08/18/21 KeyBanc
Agilent price target raised to $195 from $160 at KeyBanc
ABT Abbott
$129.07 /

+0.7 (+0.55%)

08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
08/31/21 Barclays
Abbott's Amulet could become 'needle mover,' says Barclays
08/30/21 Piper Sandler
Boston Scientific's Watchman still well positioned, says Piper Sandler
08/23/21 Cowen
Abbott price target raised to $140 from $125 at Cowen
ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

08/25/21 Citi
Arcturus Therapeutics price target lowered to $114 from $118 at Citi
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
08/03/21 Evercore ISI
Exact Sciences weakness 'exaggerated' after CFO's 10b5 sale, says Evercore ISI
07/29/21 Canaccord
Exact Sciences price target lowered to $160 from $185 at Canaccord
07/29/21 Oppenheimer
Exact Sciences price target lowered to $155 from $161 at Oppenheimer
FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
FLXN Flexion
$6.44 /

+0.165 (+2.63%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Piper Sandler
Global Blood price target lowered to $40 from $45 at Piper Sandler
JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
09/07/21 Morgan Stanley
Johnson & Johnson downgraded to Equal Weight from Overweight at Morgan Stanley
08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

08/30/21 Citi
Karuna Therapeutics initiated with a Buy at Citi
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
MDWD MediWound
$3.85 /

-0.07 (-1.79%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
MDT Medtronic
$135.13 /

+0.57 (+0.42%)

08/27/21 Argus
Medtronic price target raised to $165 from $150 at Argus
08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
08/25/21 Wells Fargo
Medtronic price target raised to $151 from $140 at Wells Fargo
PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

05/06/21 Roth Capital
Turning Point 'significantly undervalued' with catalysts ahead, says Roth
04/13/21 Roth Capital
Turning Point combo data show 'expansive pipeline potential,' says Roth Capital
04/06/21 Roth Capital
Turning Point price target raised to $175 from $170 at Roth Capital
03/02/21 Roth Capital
Turning Point has 'many value-driving catalysts' in 2021, says Roth Capital
SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

05/10/21 Oppenheimer
Service Corp. price target raised to $59 from $54 at Oppenheimer
11/02/20 Credit Suisse
Service Corp. price target raised to $55 from $50 at Credit Suisse
SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RVNC Revance
$27.35 /

+0.06 (+0.22%)

05/11/21 Mizuho
Revance price target lowered to $36 from $37 at Mizuho
04/23/21 Mizuho
Revance price target raised to $37 from $33 at Mizuho
02/23/21 Mizuho
Revance price target raised to $33 from $30 at Mizuho
02/23/21 H.C. Wainwright
Revance price target raised to $35 from $33 at H.C. Wainwright
TFX Teleflex
$400.07 /

+1.03 (+0.26%)

09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
08/02/21 KeyBanc
Teleflex price target lowered to $439 from $448 at KeyBanc
07/19/21 SVB Leerink
Teleflex downgraded to Market Perform from Outperform at SVB Leerink
07/15/21 Piper Sandler
Teleflex, Itamar pullbacks on proposed rate cuts overdone, says Piper Sandler
TECH Bio-Techne
$507.70 /

-6.81 (-1.32%)

08/24/21 Argus
Bio-Techne price target raised to $540 from $490 at Argus
08/06/21 Baird
Bio-Techne price target raised to $522 from $430 at Baird
08/05/21 Benchmark
Bio-Techne price target raised to $540 from $480 at Benchmark
06/18/21 Argus
Bio-Techne price target raised to $490 from $440 at Argus
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
TNDM TNDM
/

+

08/05/21 SVB Leerink
Tandem Diabetes price target raised to $123 from $102 at SVB Leerink
08/05/21 Craig-Hallum
Tandem Diabetes price target raised to $153 from $140 at Craig-Hallum
08/05/21 Wells Fargo
Tandem Diabetes price target raised to $121 from $112 at Wells Fargo
08/05/21 Oppenheimer
Tandem Diabetes price target raised to $140 from $135 at Oppenheimer
RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

08/12/21 SVB Leerink
Rapt Therapeutics initiated with an Outperform at SVB Leerink
07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
06/23/21 H.C. Wainwright
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright
QURE uniQure
$34.68 /

-0.24 (-0.69%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
NVTA Invitae
$31.17 /

-0.545 (-1.72%)

08/04/21 Benchmark
Invitae upgraded to Buy from Hold at Benchmark
06/21/21 Wells Fargo
Invitae price target raised to $35 from $30 at Wells Fargo
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

07/22/21 Deutsche Bank
Intuitive Surgical price target raised to $925 from $825 at Deutsche Bank
07/21/21 SVB Leerink
Intuitive Surgical price target raised to $975 from $930 at SVB Leerink
07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
07/21/21 Wells Fargo
Intuitive Surgical price target raised to $1,060 from $916 at Wells Fargo
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

TNDM TNDM
/

+

TFX Teleflex
$400.07 /

+1.03 (+0.26%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

RVNC Revance
$27.35 /

+0.06 (+0.22%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

  • 16
    Jun
  • 10
    Mar
  • 02
    Mar
  • 22
    Jan
  • 06
    Jan
  • 08
    Dec
  • 11
    Nov
  • 27
    Oct
  • 24
    Sep
NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

Conference/Events
Wells Fargo to hold a virtual conference » 17:31
09/08/21
09/08
17:31
09/08/21
17:31
A

Agilent

$178.68 /

+0.93 (+0.52%)

, ABT

Abbott

$129.07 /

+0.7 (+0.55%)

, ARCT

Arcturus Therapeutics

$55.52 /

-1.03 (-1.82%)

, COO

Cooper Companies

$454.12 /

+6.85 (+1.53%)

, EXAS

Exact Sciences

$103.47 /

-1.52 (-1.45%)

, FATE

Fate Therapeutics

$69.52 /

-3.57 (-4.88%)

, FLXN

Flexion

$6.44 /

+0.165 (+2.63%)

, GBT

Global Blood Therapeutics

$30.01 /

+0.23 (+0.77%)

, JNCE

Jounce Therapeutics

$6.51 /

+0.015 (+0.23%)

, JNJ

Johnson & Johnson

$171.88 /

-0.41 (-0.24%)

, KRTX

Karuna Therapeutics

$116.74 /

-4.93 (-4.05%)

, KZR

Kezar Life Sciences

$7.79 /

-0.03 (-0.38%)

, LNTH

Lantheus

$26.17 /

+0.06 (+0.23%)

, MDWD

MediWound

$3.85 /

-0.07 (-1.79%)

, MDT

Medtronic

$135.13 /

+0.57 (+0.42%)

, PACB

Pacific Biosciences

$29.40 /

-0.9 (-2.97%)

, TPTX

Turning Point Therapeutics

$78.16 /

-1.32 (-1.66%)

, SCI

Service Corp.

$63.46 /

+0.825 (+1.32%)

, SMFR

Sema4 Holdings

$8.68 /

-0.55 (-5.96%)

, SGMO

Sangamo

$9.83 /

-0.19 (-1.90%)

, RVNC

Revance

$27.35 /

+0.06 (+0.22%)

, TFX

Teleflex

$400.07 /

+1.03 (+0.26%)

, TECH

Bio-Techne

$507.70 /

-6.81 (-1.32%)

, TSHA

Taysha Gene Therapies

$19.76 /

-1.81 (-8.39%)

, TNDM

TNDM

/

+

, RAPT

Rapt Therapeutics

$36.06 /

-0.14 (-0.39%)

, QURE

uniQure

$34.68 /

-0.24 (-0.69%)

, NVTA

Invitae

$31.17 /

-0.545 (-1.72%)

, ITOS

iTeos Therapeutics

$28.26 /

-0.88 (-3.02%)

, ISRG

Intuitive Surgical

$1,082.15 /

+4.97 (+0.46%)

2021 Wells Fargo…

2021 Wells Fargo Healthcare Virtual Conference to be held on September 9-10.Webcast Link

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

TNDM TNDM
/

+

TFX Teleflex
$400.07 /

+1.03 (+0.26%)

TECH Bio-Techne
$507.70 /

-6.81 (-1.32%)

SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

RVNC Revance
$27.35 /

+0.06 (+0.22%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

A Agilent
$178.68 /

+0.93 (+0.52%)

08/18/21 SVB Leerink
Agilent price target raised to $170 from $160 at SVB Leerink
08/18/21 Cowen
Agilent price target raised to $165 from $150 at Cowen
08/18/21 Jefferies
Agilent price target raised to $185 from $155 at Jefferies
08/18/21 KeyBanc
Agilent price target raised to $195 from $160 at KeyBanc
ABT Abbott
$129.07 /

+0.7 (+0.55%)

08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
08/31/21 Barclays
Abbott's Amulet could become 'needle mover,' says Barclays
08/30/21 Piper Sandler
Boston Scientific's Watchman still well positioned, says Piper Sandler
08/23/21 Cowen
Abbott price target raised to $140 from $125 at Cowen
ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

08/25/21 Citi
Arcturus Therapeutics price target lowered to $114 from $118 at Citi
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
08/12/21 Raymond James
Arcturus Therapeutics downgraded to Underperform from Market Perform at Raymond James
COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
08/03/21 Evercore ISI
Exact Sciences weakness 'exaggerated' after CFO's 10b5 sale, says Evercore ISI
07/29/21 Canaccord
Exact Sciences price target lowered to $160 from $185 at Canaccord
07/29/21 Oppenheimer
Exact Sciences price target lowered to $155 from $161 at Oppenheimer
FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

08/26/21
Fly Intel: Top five analyst initiations
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/26/21 Morgan Stanley
Fate Therapeutics initiated with an Equal Weight at Morgan Stanley
08/20/21 Piper Sandler
Fate Therapeutics selloff on data a buying opportunity, says Piper Sandler
FLXN Flexion
$6.44 /

+0.165 (+2.63%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Piper Sandler
Global Blood price target lowered to $40 from $45 at Piper Sandler
JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

08/05/21 Piper Sandler
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
09/07/21 Morgan Stanley
Johnson & Johnson downgraded to Equal Weight from Overweight at Morgan Stanley
08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

08/30/21 Citi
Karuna Therapeutics initiated with a Buy at Citi
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 Jefferies
Karuna Therapeutics initiated with a Buy at Jefferies
06/30/21 Citi
Karuna Therapeutics selloff brings buying opportunity, says Citi
KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
07/20/21 JonesTrading
Kezar Life Sciences initiated with a Buy at JonesTrading
LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
MDWD MediWound
$3.85 /

-0.07 (-1.79%)

06/29/21 Oppenheimer
MediWound NexoBrid CRL as expected, says Oppenheimer
03/02/21 Aegis
MediWound initiated with a Buy at Aegis
02/26/21 H.C. Wainwright
MediWound price target raised to $7 from $5.50 at H.C. Wainwright
10/19/20 BTIG
Vericel price target raised to $30 from $23 at BTIG
MDT Medtronic
$135.13 /

+0.57 (+0.42%)

08/27/21 Argus
Medtronic price target raised to $165 from $150 at Argus
08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
08/25/21 Wells Fargo
Medtronic price target raised to $151 from $140 at Wells Fargo
PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

05/06/21 Roth Capital
Turning Point 'significantly undervalued' with catalysts ahead, says Roth
04/13/21 Roth Capital
Turning Point combo data show 'expansive pipeline potential,' says Roth Capital
04/06/21 Roth Capital
Turning Point price target raised to $175 from $170 at Roth Capital
03/02/21 Roth Capital
Turning Point has 'many value-driving catalysts' in 2021, says Roth Capital
SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

05/10/21 Oppenheimer
Service Corp. price target raised to $59 from $54 at Oppenheimer
11/02/20 Credit Suisse
Service Corp. price target raised to $55 from $50 at Credit Suisse
SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
RVNC Revance
$27.35 /

+0.06 (+0.22%)

05/11/21 Mizuho
Revance price target lowered to $36 from $37 at Mizuho
04/23/21 Mizuho
Revance price target raised to $37 from $33 at Mizuho
02/23/21 Mizuho
Revance price target raised to $33 from $30 at Mizuho
02/23/21 H.C. Wainwright
Revance price target raised to $35 from $33 at H.C. Wainwright
TFX Teleflex
$400.07 /

+1.03 (+0.26%)

09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
08/02/21 KeyBanc
Teleflex price target lowered to $439 from $448 at KeyBanc
07/19/21 SVB Leerink
Teleflex downgraded to Market Perform from Outperform at SVB Leerink
07/15/21 Piper Sandler
Teleflex, Itamar pullbacks on proposed rate cuts overdone, says Piper Sandler
TECH Bio-Techne
$507.70 /

-6.81 (-1.32%)

08/24/21 Argus
Bio-Techne price target raised to $540 from $490 at Argus
08/06/21 Baird
Bio-Techne price target raised to $522 from $430 at Baird
08/05/21 Benchmark
Bio-Techne price target raised to $540 from $480 at Benchmark
06/18/21 Argus
Bio-Techne price target raised to $490 from $440 at Argus
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
TNDM TNDM
/

+

08/05/21 SVB Leerink
Tandem Diabetes price target raised to $123 from $102 at SVB Leerink
08/05/21 Craig-Hallum
Tandem Diabetes price target raised to $153 from $140 at Craig-Hallum
08/05/21 Wells Fargo
Tandem Diabetes price target raised to $121 from $112 at Wells Fargo
08/05/21 Oppenheimer
Tandem Diabetes price target raised to $140 from $135 at Oppenheimer
RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

08/12/21 SVB Leerink
Rapt Therapeutics initiated with an Outperform at SVB Leerink
07/12/21 Roth Capital
Roth adds more 'SMID-cap' names to second half top picks
06/23/21 JMP Securities
JMP raises Evelo Biosciences price target to $38 after Rapt reports data
06/23/21 H.C. Wainwright
Rapt Therapeutics price target raised to $56 from $29 at H.C. Wainwright
QURE uniQure
$34.68 /

-0.24 (-0.69%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
NVTA Invitae
$31.17 /

-0.545 (-1.72%)

08/04/21 Benchmark
Invitae upgraded to Buy from Hold at Benchmark
06/21/21 Wells Fargo
Invitae price target raised to $35 from $30 at Wells Fargo
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
06/15/21 Raymond James
Invitae initiated with an Outperform at Raymond James
ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

07/22/21 Deutsche Bank
Intuitive Surgical price target raised to $925 from $825 at Deutsche Bank
07/21/21 SVB Leerink
Intuitive Surgical price target raised to $975 from $930 at SVB Leerink
07/21/21 Evercore ISI
Intuitive Surgical price target raised to $980 from $825 at Evercore ISI
07/21/21 Wells Fargo
Intuitive Surgical price target raised to $1,060 from $916 at Wells Fargo
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

TNDM TNDM
/

+

TFX Teleflex
$400.07 /

+1.03 (+0.26%)

SGMO Sangamo
$9.83 /

-0.19 (-1.90%)

SCI Service Corp.
$63.46 /

+0.825 (+1.32%)

RVNC Revance
$27.35 /

+0.06 (+0.22%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

KZR Kezar Life Sciences
$7.79 /

-0.03 (-0.38%)

KRTX Karuna Therapeutics
$116.74 /

-4.93 (-4.05%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

  • 16
    Jun
  • 10
    Mar
  • 02
    Mar
  • 22
    Jan
  • 06
    Jan
  • 08
    Dec
  • 11
    Nov
  • 27
    Oct
  • 24
    Sep
NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

TPTX Turning Point Therapeutics
$78.16 /

-1.32 (-1.66%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

LNTH Lantheus
$26.17 /

+0.06 (+0.23%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

JNCE Jounce Therapeutics
$6.51 /

+0.015 (+0.23%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

GBT Global Blood Therapeutics
$30.01 /

+0.23 (+0.77%)

FLXN Flexion
$6.44 /

+0.165 (+2.63%)

FATE Fate Therapeutics
$69.52 /

-3.57 (-4.88%)

EXAS Exact Sciences
$103.47 /

-1.52 (-1.45%)

ARCT Arcturus Therapeutics
$55.52 /

-1.03 (-1.82%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

SMFR Sema4 Holdings
$8.68 /

-0.55 (-5.96%)

RAPT Rapt Therapeutics
$36.06 /

-0.14 (-0.39%)

PACB Pacific Biosciences
$29.40 /

-0.9 (-2.97%)

NVTA Invitae
$31.17 /

-0.545 (-1.72%)

MDWD MediWound
$3.85 /

-0.07 (-1.79%)

MDT Medtronic
$135.13 /

+0.57 (+0.42%)

JNJ Johnson & Johnson
$171.88 /

-0.41 (-0.24%)

ITOS iTeos Therapeutics
$28.26 /

-0.88 (-3.02%)

ISRG Intuitive Surgical
$1,082.15 /

+4.97 (+0.46%)

COO Cooper Companies
$454.12 /

+6.85 (+1.53%)

ABT Abbott
$129.07 /

+0.7 (+0.55%)

A Agilent
$178.68 /

+0.93 (+0.52%)

Over a month ago
Recommendations
Jounce Therapeutics price target lowered to $17 from $20 at Piper Sandler » 15:17
08/05/21
08/05
15:17
08/05/21
15:17
JNCE

Jounce Therapeutics

$5.26 /

+0.13 (+2.53%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff lowered the firm's price target on Jounce Therapeutics to $17 from $20 as he has rolled forward his discount period to mid-22 following the company's Q2 report. Jounce ended Q2 with cash to advance its innovative I-O pipeline and fund the company into Q3 of 2023, noted Tenthoff, who keeps an Overweight rating on the shares.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$5.26 /

+0.13 (+2.53%)

JNCE Jounce Therapeutics
$5.26 /

+0.13 (+2.53%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$5.26 /

+0.13 (+2.53%)

  • 10
    Mar
JNCE Jounce Therapeutics
$5.26 /

+0.13 (+2.53%)

Hot Stocks
Jounce Therapeutics expects cash to fund requirements through 3Q23 » 07:24
08/05/21
08/05
07:24
08/05/21
07:24
JNCE

Jounce Therapeutics

$5.13 /

-0.06 (-1.16%)

Based on its current…

Based on its current operating and development plans, Jounce continues to expect gross cash burn on operating expenses and capital expenditures for the full year 2021 to be approximately $95.0 million to $110.0 million. Given the strength of its balance sheet, Jounce expects its existing cash, cash equivalents and investments to be sufficient to enable the funding of its operating expenses and capital expenditure requirements through the third quarter of 2023.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

  • 10
    Mar
JNCE Jounce Therapeutics
$5.13 /

-0.06 (-1.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.